Suppr超能文献

智利圣地亚哥基于大量 RT-qPCR 检测 SARS-CoV-2 的数据集进行再感染率的生态学研究。

An ecological study on reinfection rates using a large dataset of RT-qPCR tests for SARS-CoV-2 in Santiago of Chile.

机构信息

Departamento de Biología, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile.

Centro de Biotecnología Acuícola, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile.

出版信息

Front Public Health. 2023 Jul 10;11:1191377. doi: 10.3389/fpubh.2023.1191377. eCollection 2023.

Abstract

INTRODUCTION

As the SARS-CoV-2 continues to evolve, new variants pose a significant threat by potentially overriding the immunity conferred by vaccination and natural infection. This scenario can lead to an upswing in reinfections, amplified baseline epidemic activity, and localized outbreaks. In various global regions, estimates of breakthrough cases associated with the currently circulating viral variants, such as Omicron, have been reported. Nonetheless, specific data on the reinfection rate in Chile still needs to be included.

METHODS

Our study has focused on estimating COVID-19 reinfections per wave based on a sample of 578,670 RT-qPCR tests conducted at the University of Santiago of Chile (USACH) from April 2020 to July 2022, encompassing 345,997 individuals.

RESULTS

The analysis reveals that the highest rate of reinfections transpired during the fourth and fifth COVID-19 waves, primarily driven by the Omicron variant. These findings hold despite 80% of the Chilean population receiving complete vaccination under the primary scheme and 60% receiving at least one booster dose. On average, the interval between initial infection and reinfection was found to be 372 days. Interestingly, reinfection incidence was higher in women aged between 30 and 55. Additionally, the viral load during the second infection episode was lower, likely attributed to Chile's high vaccination rate.

DISCUSSION

This study demonstrates that the Omicron variant is behind Chile's highest number of reinfection cases, underscoring its potential for immune evasion. This vital epidemiological information contributes to developing and implementing effective public health policies.

摘要

简介

随着 SARS-CoV-2 的持续进化,新的变种通过潜在地颠覆疫苗和自然感染所赋予的免疫力,构成了重大威胁。这种情况可能导致再次感染的增加、基础流行活动的放大和局部爆发。在全球各个地区,都有报道称与当前流行的病毒变种(如奥密克戎)相关的突破性病例的估计。然而,智利再感染率的具体数据仍有待纳入。

方法

我们的研究集中于根据智利圣地亚哥大学(USACH)从 2020 年 4 月至 2022 年 7 月进行的 578670 次 RT-qPCR 测试的样本,估计每一波 COVID-19 再感染,涵盖了 345997 个人。

结果

分析表明,第四次和第五次 COVID-19 波期间再感染率最高,主要由奥密克戎变种驱动。尽管智利 80%的人口按照初级方案完全接种疫苗,60%的人至少接种了一剂加强针,但仍出现了这些发现。平均而言,初次感染和再次感染之间的间隔为 372 天。有趣的是,30 至 55 岁的女性中再感染的发生率更高。此外,第二次感染时的病毒载量较低,可能归因于智利的高疫苗接种率。

讨论

这项研究表明,奥密克戎变种是智利再感染病例最多的原因,突出了其免疫逃避的潜力。这些重要的流行病学信息有助于制定和实施有效的公共卫生政策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afeb/10364051/5b07994f6af6/fpubh-11-1191377-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验